Clinical Trial Update: Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial BY9010/M1-207 evaluating the efficacy and safety of inhaled ciclesonide in preschool children aged 2 to 6 years with asthma has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Ciclesonide (Alvesco) (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED